# Sanmina Corp: financial statements, quarterly

SANM · Nasdaq · CIK 897723 · [Technology](/sectors/technology.md) · fiscal year ends Oct 3

Pages: [Overview](/companies/sanm.md) · [Financials](/companies/sanm/financials.md) · [Filings](/companies/sanm/filings.md) · [Insiders](/companies/sanm/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/sanm/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-09-30) | Q1 FY2024 (2023-12-30) | Q2 FY2024 (2024-03-30) | Q3 FY2024 (2024-06-29) | Q4 FY2024 (2024-09-28) | Q1 FY2025 (2024-12-28) | Q2 FY2025 (2025-03-29) | Q3 FY2025 (2025-06-28) | Q4 FY2025 (2025-09-27) | Q1 FY2026 (2025-12-27) | Q2 FY2026 (2026-03-28) | Q3 FY2026 (2026-06-27) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [2,052 d](/filings/0000897723-25-000042.md) | [1,875](/filings/0000897723-25-000007.md) | [1,835](/filings/0000897723-25-000016.md) | [1,841](/filings/0000897723-25-000031.md) | [2,018 d](/filings/0000897723-25-000042.md) | [2,006](/filings/0000897723-26-000015.md) | [1,984](/filings/0000897723-26-000025.md) | [2,042](/filings/0000897723-26-000037.md) | [2,096 d](/filings/0000897723-25-000042.md) | [3,190](/filings/0000897723-26-000015.md) | [4,013](/filings/0000897723-26-000025.md) | [3,464](/filings/0000897723-26-000037.md) |
| Cost of revenue | $m | [1,879 d](/filings/0000897723-25-000042.md) | [1,714](/filings/0000897723-25-000007.md) | [1,680](/filings/0000897723-25-000016.md) | [1,688](/filings/0000897723-25-000031.md) | [1,846 d](/filings/0000897723-25-000042.md) | [1,838](/filings/0000897723-26-000015.md) | [1,808](/filings/0000897723-26-000025.md) | [1,861](/filings/0000897723-26-000037.md) | [1,905 d](/filings/0000897723-25-000042.md) | [2,947](/filings/0000897723-26-000015.md) | [3,659](/filings/0000897723-26-000025.md) | [3,101](/filings/0000897723-26-000037.md) |
| Gross profit | $m | [173 d](/filings/0000897723-25-000042.md) | [161](/filings/0000897723-25-000007.md) | [155](/filings/0000897723-25-000016.md) | [154](/filings/0000897723-25-000031.md) | [171 d](/filings/0000897723-25-000042.md) | [168](/filings/0000897723-26-000015.md) | [176](/filings/0000897723-26-000025.md) | [181](/filings/0000897723-26-000037.md) | [191 d](/filings/0000897723-25-000042.md) | [242](/filings/0000897723-26-000015.md) | [354](/filings/0000897723-26-000025.md) | [363](/filings/0000897723-26-000037.md) |
| Research and development | $m | [7.7 d](/filings/0000897723-25-000042.md) | [6.3](/filings/0000897723-25-000007.md) | [6.3](/filings/0000897723-25-000016.md) | [7.7](/filings/0000897723-25-000031.md) | [8.2 d](/filings/0000897723-25-000042.md) | [7.0](/filings/0000897723-26-000015.md) | [7.3](/filings/0000897723-26-000025.md) | [8.1](/filings/0000897723-26-000037.md) | [8.7 d](/filings/0000897723-25-000042.md) | [8.7](/filings/0000897723-26-000015.md) | [8.0](/filings/0000897723-26-000025.md) | [8.3](/filings/0000897723-26-000037.md) |
| Selling, general and administrative | $m | [62.1 d](/filings/0000897723-25-000042.md) | [64.8](/filings/0000897723-25-000007.md) | [69.2](/filings/0000897723-25-000016.md) | [61.7](/filings/0000897723-25-000031.md) | [70.5 d](/filings/0000897723-25-000042.md) | [70.8](/filings/0000897723-26-000015.md) | [76.3](/filings/0000897723-26-000025.md) | [69.5](/filings/0000897723-26-000037.md) | [73.5 d](/filings/0000897723-25-000042.md) | [115](/filings/0000897723-26-000015.md) | [114](/filings/0000897723-26-000025.md) | [109](/filings/0000897723-26-000037.md) |
| Operating income | $m | [99.3 d](/filings/0000897723-25-000042.md) | [87.6](/filings/0000897723-25-000007.md) | [76.0](/filings/0000897723-25-000016.md) | [82.4](/filings/0000897723-25-000031.md) | [89.6 d](/filings/0000897723-25-000042.md) | [88.6](/filings/0000897723-26-000015.md) | [91.6](/filings/0000897723-26-000025.md) | [95.9](/filings/0000897723-26-000037.md) | [78.5 d](/filings/0000897723-25-000042.md) | [73.6](/filings/0000897723-26-000015.md) | [157](/filings/0000897723-26-000025.md) | [221](/filings/0000897723-26-000037.md) |
| Interest expense | $m | [8.3 d](/filings/0000897723-23-000028.md) | [8.4](/filings/0000897723-24-000009.md) | [8.2](/filings/0000897723-24-000031.md) | [7.5](/filings/0000897723-25-000031.md) | [5.0 d](/filings/0000897723-25-000042.md) | [5.0](/filings/0000897723-26-000015.md) | [5.0](/filings/0000897723-26-000025.md) | [5.0](/filings/0000897723-26-000037.md) | [5.2 d](/filings/0000897723-25-000042.md) | [24.7](/filings/0000897723-26-000015.md) | [32.1](/filings/0000897723-26-000025.md) | [32.5](/filings/0000897723-26-000037.md) |
| Income tax | $m | [21.4 d](/filings/0000897723-25-000042.md) | [21.3](/filings/0000897723-25-000007.md) | [19.1](/filings/0000897723-25-000016.md) | [19.9](/filings/0000897723-25-000031.md) | [19.4 d](/filings/0000897723-25-000042.md) | [15.4](/filings/0000897723-26-000015.md) | [17.9](/filings/0000897723-26-000025.md) | [18.5](/filings/0000897723-26-000037.md) | [21.4 d](/filings/0000897723-25-000042.md) | [9.8](/filings/0000897723-26-000015.md) | [33.3](/filings/0000897723-26-000025.md) | [66.4](/filings/0000897723-26-000037.md) |
| Net income | $m | [61.8 d](/filings/0000897723-25-000042.md) | [57.1](/filings/0000897723-25-000007.md) | [52.5](/filings/0000897723-25-000016.md) | [51.6](/filings/0000897723-25-000031.md) | [61.4 d](/filings/0000897723-25-000042.md) | [65.0](/filings/0000897723-26-000015.md) | [64.2](/filings/0000897723-26-000025.md) | [68.6](/filings/0000897723-26-000037.md) | [48.1 d](/filings/0000897723-25-000042.md) | [49.3](/filings/0000897723-26-000015.md) | [93.6](/filings/0000897723-26-000025.md) | [117](/filings/0000897723-26-000037.md) |
| Diluted EPS | $ per share | not reported | [0.98](/filings/0000897723-25-000007.md) | [0.93](/filings/0000897723-25-000016.md) | [0.91](/filings/0000897723-25-000031.md) | not reported | [1.16](/filings/0000897723-26-000015.md) | [1.16](/filings/0000897723-26-000025.md) | [1.26](/filings/0000897723-26-000037.md) | not reported | [0.89](/filings/0000897723-26-000015.md) | [1.70](/filings/0000897723-26-000025.md) | [2.12](/filings/0000897723-26-000037.md) |
| Basic EPS | $ per share | not reported | [1.01](/filings/0000897723-25-000007.md) | [0.94](/filings/0000897723-25-000016.md) | [0.93](/filings/0000897723-25-000031.md) | not reported | [1.20](/filings/0000897723-26-000015.md) | [1.18](/filings/0000897723-26-000025.md) | [1.28](/filings/0000897723-26-000037.md) | not reported | [0.91](/filings/0000897723-26-000015.md) | [1.72](/filings/0000897723-26-000025.md) | [2.17](/filings/0000897723-26-000037.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-09-30) | Q1 FY2024 (2023-12-30) | Q2 FY2024 (2024-03-30) | Q3 FY2024 (2024-06-29) | FY2024 (2024-09-28) | Q1 FY2025 (2024-12-28) | Q2 FY2025 (2025-03-29) | Q3 FY2025 (2025-06-28) | FY2025 (2025-09-27) | Q1 FY2026 (2025-12-27) | Q2 FY2026 (2026-03-28) | Q3 FY2026 (2026-06-27) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [668](/filings/0000897723-24-000056.md) | [632](/filings/0000897723-24-000009.md) | [651](/filings/0000897723-24-000031.md) | [658](/filings/0000897723-24-000046.md) | [626](/filings/0000897723-25-000042.md) | [642](/filings/0000897723-25-000007.md) | [647](/filings/0000897723-25-000016.md) | [798](/filings/0000897723-25-000031.md) | [926](/filings/0000897723-26-000037.md) | [1,416](/filings/0000897723-26-000015.md) | [1,576](/filings/0000897723-26-000025.md) | [1,845](/filings/0000897723-26-000037.md) |
| Current assets | $m | [3,880](/filings/0000897723-24-000056.md) | [3,630](/filings/0000897723-24-000009.md) | [3,697](/filings/0000897723-24-000031.md) | [3,693](/filings/0000897723-24-000046.md) | [3,870](/filings/0000897723-25-000042.md) | [3,876](/filings/0000897723-25-000007.md) | [4,067](/filings/0000897723-25-000016.md) | [4,302](/filings/0000897723-25-000031.md) | [4,865](/filings/0000897723-26-000037.md) | [7,853](/filings/0000897723-26-000015.md) | [7,611](/filings/0000897723-26-000025.md) | [7,828](/filings/0000897723-26-000037.md) |
| Total assets | $m | [4,874](/filings/0000897723-24-000056.md) | [4,617](/filings/0000897723-24-000009.md) | [4,686](/filings/0000897723-24-000031.md) | [4,664](/filings/0000897723-24-000046.md) | [4,823](/filings/0000897723-25-000042.md) | [4,812](/filings/0000897723-25-000007.md) | [4,967](/filings/0000897723-25-000016.md) | [5,222](/filings/0000897723-25-000031.md) | [5,858](/filings/0000897723-26-000037.md) | [9,801](/filings/0000897723-26-000015.md) | [9,669](/filings/0000897723-26-000025.md) | [9,740](/filings/0000897723-26-000037.md) |
| Current liabilities | $m | [2,033](/filings/0000897723-24-000056.md) | [1,822](/filings/0000897723-24-000009.md) | [1,848](/filings/0000897723-24-000031.md) | [1,822](/filings/0000897723-24-000046.md) | [1,941](/filings/0000897723-25-000042.md) | [1,883](/filings/0000897723-25-000007.md) | [2,073](/filings/0000897723-25-000016.md) | [2,248](/filings/0000897723-25-000031.md) | [2,822](/filings/0000897723-26-000037.md) | [4,615](/filings/0000897723-26-000015.md) | [4,442](/filings/0000897723-26-000025.md) | [4,397](/filings/0000897723-26-000037.md) |
| Long-term debt | $m | [312](/filings/0000897723-24-000056.md) | [308](/filings/0000897723-24-000009.md) | [304](/filings/0000897723-24-000031.md) | [300](/filings/0000897723-24-000046.md) | [300](/filings/0000897723-25-000042.md) | [296](/filings/0000897723-25-000007.md) | [291](/filings/0000897723-25-000016.md) | [287](/filings/0000897723-25-000031.md) | [283](/filings/0000897723-26-000037.md) | [1,999](/filings/0000897723-26-000015.md) | [2,000](/filings/0000897723-26-000025.md) | [1,957](/filings/0000897723-26-000037.md) |
| Current portion of debt | $m | [25.9](/filings/0000897723-24-000056.md) | [17.5](/filings/0000897723-24-000009.md) | [17.5](/filings/0000897723-24-000031.md) | [17.5](/filings/0000897723-24-000046.md) | [17.5](/filings/0000897723-25-000042.md) | [17.5](/filings/0000897723-25-000007.md) | [17.5](/filings/0000897723-25-000016.md) | [17.5](/filings/0000897723-25-000031.md) | [17.5](/filings/0000897723-26-000037.md) | [172](/filings/0000897723-26-000015.md) | [172](/filings/0000897723-26-000025.md) | [215](/filings/0000897723-26-000037.md) |
| Short-term borrowings | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [2,319](/filings/0000897723-25-000042.md) | [2,273](/filings/0000897723-25-000007.md) | [2,327](/filings/0000897723-25-000016.md) | [2,341](/filings/0000897723-25-000031.md) | [2,362](/filings/0000897723-25-000042.md) | [2,421](/filings/0000897723-26-000015.md) | [2,396](/filings/0000897723-26-000025.md) | [2,475](/filings/0000897723-26-000037.md) | [2,539](/filings/0000897723-26-000037.md) | [2,661](/filings/0000897723-26-000015.md) | [2,612](/filings/0000897723-26-000025.md) | [2,760](/filings/0000897723-26-000037.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:DebtCurrent
- Short-term borrowings: not reported
- Shareholders' equity: us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-09-30) | Q1 FY2024 (2023-12-30) | Q2 FY2024 (2024-03-30) | Q3 FY2024 (2024-06-29) | Q4 FY2024 (2024-09-28) | Q1 FY2025 (2024-12-28) | Q2 FY2025 (2025-03-29) | Q3 FY2025 (2025-06-28) | Q4 FY2025 (2025-09-27) | Q1 FY2026 (2025-12-27) | Q2 FY2026 (2026-03-28) | Q3 FY2026 (2026-06-27) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [76.9 d](/filings/0000897723-25-000042.md) | [126](/filings/0000897723-25-000007.md) | [72.3 d](/filings/0000897723-25-000016.md) | [90.0 d](/filings/0000897723-25-000031.md) | [51.9 d](/filings/0000897723-25-000042.md) | [63.9](/filings/0000897723-26-000015.md) | [157 d](/filings/0000897723-26-000025.md) | [201 d](/filings/0000897723-26-000037.md) | [199 d](/filings/0000897723-25-000042.md) | [179](/filings/0000897723-26-000015.md) | [399 d](/filings/0000897723-26-000025.md) | [124 d](/filings/0000897723-26-000037.md) |
| Capital expenditure | $m | [39.2 d](/filings/0000897723-25-000042.md) | [34.2](/filings/0000897723-25-000007.md) | [29.6 d](/filings/0000897723-25-000016.md) | [24.4 d](/filings/0000897723-25-000031.md) | [23.0 d](/filings/0000897723-25-000042.md) | [17.1](/filings/0000897723-26-000015.md) | [30.7 d](/filings/0000897723-26-000025.md) | [37.1 d](/filings/0000897723-26-000037.md) | [62.5 d](/filings/0000897723-25-000042.md) | [86.8](/filings/0000897723-26-000015.md) | [56.7 d](/filings/0000897723-26-000025.md) | [101 d](/filings/0000897723-26-000037.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: not reported

## Shares

| Line item | Unit | Q1 FY2023 (2022-12-31) | Q2 FY2023 (2023-04-01) | Q3 FY2023 (2023-07-01) | Q1 FY2024 (2023-12-30) | Q2 FY2024 (2024-03-30) | Q3 FY2024 (2024-06-29) | Q1 FY2025 (2024-12-28) | Q2 FY2025 (2025-03-29) | Q3 FY2025 (2025-06-28) | Q1 FY2026 (2025-12-27) | Q2 FY2026 (2026-03-28) | Q3 FY2026 (2026-06-27) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [59.9](/filings/0000897723-24-000009.md) | [59.8](/filings/0000897723-24-000031.md) | [59.6](/filings/0000897723-24-000046.md) | [58.2](/filings/0000897723-25-000007.md) | [56.7](/filings/0000897723-25-000016.md) | [56.7](/filings/0000897723-25-000031.md) | [55.9](/filings/0000897723-26-000015.md) | [55.5](/filings/0000897723-26-000025.md) | [54.5](/filings/0000897723-26-000037.md) | [55.5](/filings/0000897723-26-000015.md) | [55.1](/filings/0000897723-26-000025.md) | [55.1](/filings/0000897723-26-000037.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 53,597,356 at 2026-07-20, from the cover of the [10-Q filed 2026-07-27](/filings/0000897723-26-000037.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:27 ET. No prices; not investment advice.